The scientists from A*STAR’s Institute of Medical Biology (IMB) and Institute of Molecular and Cell Biology (IMCB) developed a novel methodology to probe single cells for various DNA-methylation errors at multiple loci to reveal failed maintenance of epigenetic mark results in chimeric mice, which display unpredictable phenotypes leading to developmental arrest. This methodology allows the use of a special technique utilizing a microfluidic device to safely extract one cell for performing the assay called “pronuclear transfer” to ameliorate reprogramming defects in embryos. This study not only details the epigenetic reprogramming dynamics in early mammalian embryos, but it also suggests diagnostic and potential future therapeutic applications.
Source: Science, 2013 Sept 6
As skin ages, it may become more sensitive to its environment. A small amount of…
A father’s health before conception may play a larger role in a child’s future biology…
Two people can be the same chronological age, yet their skin may appear to age…
Your skin is often the first place where aging becomes visible. Fine lines, dryness, uneven…
Skincare has been moving steadily away from one-size-fits-all routines and toward measurement-led personalization. One reason…
Consumers often describe a familiar problem: skin that seems to lose firmness, glow, and smoothness…